Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.250
-0.010 (-0.44%)
At close: Jun 11, 2026, 4:00 PM EDT
2.259
+0.009 (0.39%)
After-hours: Jun 11, 2026, 6:58 PM EDT
Cellectar Biosciences Employees
Cellectar Biosciences had 11 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
11
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,894,632
Market Cap
17.98M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 11 | 0 | - |
| Dec 31, 2024 | 11 | -9 | -45.00% |
| Dec 31, 2023 | 20 | 5 | 33.33% |
| Dec 31, 2022 | 15 | 3 | 25.00% |
| Dec 31, 2021 | 12 | 1 | 9.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Werewolf Therapeutics | 39 |
| Curis | 24 |
| Passage Bio | 24 |
| NewcelX | 12 |
| Exicure | 8 |
| AEON Biopharma | 8 |
| Traws Pharma | 7 |
| Akari Therapeutics, | 6 |
CLRB News
- 10 days ago - Cellectar Biosciences to Highlight Compelling New Efficacy Data from Phase 2b CLOVER WaM Study of Iopofosine I 131 in r/r Waldenström Macroglobulinemia at the American Society of Clinical Oncology Annual Meeting - GlobeNewsWire
- 10 days ago - Cellectar Biosciences Slides: Corporate presentation - Filings
- 13 days ago - Cellectar Biosciences Registration statement: Registration filing - Filings
- 14 days ago - Cellectar Biosciences Proxy statement: Proxy filing - Filings
- 14 days ago - Cellectar Biosciences Proxy statement: Proxy filing - Filings
- 23 days ago - Cellectar Biosciences files to sell 51.21M shares of common stock for holders - TheFly
- 23 days ago - Cellectar Biosciences Registration statement: Registration filing - Filings
- 24 days ago - Cellectar Biosciences Proxy statement: Proxy filing - Filings